|
Group-NKTR
(N=516)
|
Group-KTR
(N=194)
|
Total
|
P
|
Intravenous hormones, n (%) |
31(6.0%) |
83(42.8%) |
114(16.1%) |
0.000 |
Azvudine, n (%) |
77(14.9%) |
112(57.7%) |
189(26.6%) |
0.000 |
Paxlovid, n (%) |
125(24.2%) |
77(39.7%) |
202(28.5%) |
0.000 |
Monoclonal antibodies, n (%) |
0(0.0%) |
8(4.1%) |
8(1.1%) |
0.000 |
Proglobulin, n (%) |
5(1.0%) |
35(18.0%) |
40(5.6%) |
0.000 |
Oxygenation, n (%) |
239(46.3%) |
17(8.8%) |
256(36.1%) |
0.000 |
Time O to P*, d, median (IQR) |
0.0(0.0,4.0) |
0.0(0.0,3.0) |
0.0(0.0,4.0) |
0.481 |
Time O to N*, d, median (IQR) |
9.0(12.0,16.0) |
15.0(20.5,25.8) |
10.0(14.0,21.0) |
0.000 |
Time O to D*, d, median (IQR) |
9.0(12.0,16.0) |
18.8(24.0,29.0) |
9.0(14.0,21.0) |
0.000 |
Time O to A*, d, median (IQR) |
2.0(5.0,8.0) |
7.0(11.0,16.0) |
2.0(6.0,10.0) |
0.000 |
Days of hospitalization, d, median (IQR) |
4.0(7.0,9.0) |
8.0(11.0,16.0) |
5.0(7.0,11.0) |
0.000 |